Zobrazeno 1 - 5
of 5
pro vyhledávání: '"N. Yu. Antimonik"'
Autor:
N. V. Zhukova, R. V. Orlova, N. Yu. Antimonik, S. I. Kutukova, N. P. Belyak, N. V. Popova, S. P. Erdniev
Publikováno v:
Issledovaniâ i Praktika v Medicine, Vol 5, Iss 2, Pp 130-140 (2018)
The incidence and mortality of skin melanoma in the world and in Russia is growing every year. It should be noted that the proportion of patients with melanoma of late stages remains high. Until recently, only ineffective chemotherapy regimens were a
Externí odkaz:
https://doaj.org/article/05d11aabd36b43cd8f78ea4df319622e
Autor:
N. V. Dobrova, N. N. Semenov, G. M. Manikhas, N. Yu. Antimonik, Yu. V. Vakhabova, S. L. Gutorov
Publikováno v:
Тазовая хирургия и онкология, Vol 0, Iss 4, Pp 50-56 (2015)
The aim of this study was to estimate efficacy of first line chemotherapy with bevacizumab in metastatic colorectal cancer patients and investigate the impact of different prognostic factors on treatment outcome.Methods.During 2004–2008 48 colorect
Externí odkaz:
https://doaj.org/article/a50609e0d07a48ba82192715a122ac21
Autor:
R. V. Orlova, N. Yu. Antimonik, D. S. Pasekov, O. A. Nagornaya, T. F. Savostyanov, N. V. Alyoshina, A. S. Levina
Publikováno v:
Medical alphabet. 3:9-17
Erdheim-Chester disease (ECD) is a rare systemic disease with an unknown etiology, which is characterized by infiltration of the organs CD68+, CD1a by non-langerhans cell histiocytes and occupies an intermediate position between malignant and immune
Autor:
M M Konstantinova, R F Savkova, L V Demidov, V A Gorbunova, G Yu Kharkevich, N Yu Antimonik, V N Merkulov, E E Simanovich, K V Ral'chenko, O V Sbrodov
Publikováno v:
Современная онкология, Vol 11, Iss 3, Pp 70-76 (2009)
Вроссийском многоцентровом нерандомизированном клиническом исследовании, включившем 92 больных в возрасте от 20 до 82 лет с морфологичес
Externí odkaz:
https://doaj.org/article/60febdfd8d194b20aa8d152f9db665ec
Publikováno v:
Современная онкология, Vol 16, Iss 1, Pp 65-69 (2014)
The article presents the clinical cases of sorafenib treatment of hepatocellular carcinoma. The experience of the Russian oncologistsdoes not only confirm the results of the international clinical research, but also demonstrates the possibility of pr